期刊文献+

健脾化湿祛瘀汤治疗非酒精性脂肪性肝炎30例

Valvation on Effect of Huashi-Quyu Decoction in Treating Nonalcohlic Steatohepatitis(NASH)
下载PDF
导出
摘要 目的观察自拟健脾化湿祛瘀汤治疗非酒精性脂肪性肝炎的临床疗效。方法将60例非酒精性脂肪性肝炎患者随机分为两组,治疗组30例服用自拟健脾化湿祛瘀汤剂,对照组30例应用水飞蓟宾胶囊,治疗一疗程即12周,疗程结束后继续随访12周。结果治疗组总疗效、临床症状各组以及B超表现均优于治疗前,有统计学意义(P<0.05)。结论自拟健脾化湿祛瘀汤治疗非酒精性脂肪性肝炎有一定的疗效,值得进一步研究。 Objective To observe the effect of Huashi-Quyu decoction in treating Nonalcohlic Steatohepatitis (NASH). Method We divided 60 cases patients of NASH into treatment group and control group randomly,30 cases for each group. Treatment group were given Huashi-Quyu decoction, while control group were took silibinin capsules. After 12 weeks of treatment, we continue followed up for 12 weeks. Results 1. The total effective rate of treatment group was 86.2% , while the control group was 74. 1%. The two groups have obvious differences in the total effect and syndromes of Chinese medicine(P 〈 0.05 ). Conclusion Huashi-Quyu decoction can improve the clinical symptoms of NASH patients, which has certain curative effect and deserves further study.
出处 《光明中医》 2014年第11期2292-2293,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 积聚 肝积 非酒精性脂肪性肝炎 健脾化湿祛瘀汤 疗效评价 Huashi-Quyu decoction Nonalcohlic Steatohepatitis ( NASH ) Chinese medicine Clinical research
  • 相关文献

参考文献4

  • 1范建高,曾民德,王均溶,等.上海市机关职员脂肪肝流行病学研究[J].中华流行病学杂志,1998,19,(1一A):409411.
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 3沈映君.中药药理学[M].北京:人民卫生出版社,2002.255-256.
  • 4翁维良.降血脂中草药研究进展[J].天津中医,1986,(1):34.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1610

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部